930790-54-8

Basic information

• Product Name: 5-CHLORO-7-METHYL-6-AZAINDOLE
• Synonyms: 5-CHLORO-7-METHYL-6-AZAINDOLE;1H-Pyrrolo[2,3-c]pyridine, 5-chloro-7-Methyl-;5-Chloro-7-methyl-1H-pyrrolo[2,3-c]pyridine
• CAS NO: 930790-54-8
• Molecular Formula: C8H7ClN2
• Molecular Weight: 166.61
• Mol File: 930790-54-8.mol

Chemical Properties

• Boiling Point: 324.6±37.0 °C(Predicted)
• Appearance: /
• Density: 1.351±0.06 g/cm3(Predicted)
• PKA: 14.05±0.40(Predicted)
• CAS DataBase Reference: 5-CHLORO-7-METHYL-6-AZAINDOLE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-CHLORO-7-METHYL-6-AZAINDOLE(930790-54-8)
• EPA Substance Registry System: 5-CHLORO-7-METHYL-6-AZAINDOLE(930790-54-8)

Safety Data

• Hazardous Substances Data: 930790-54-8(Hazardous Substances Data)

Usage

Uses

Used in Organic Chemistry:
5-CHLORO-7-METHYL-6-AZAINDOLE is used as a building block in the synthesis of various chemical compounds due to its unique structure and reactivity.
Used in Drug Synthesis:
5-CHLORO-7-METHYL-6-AZAINDOLE is used as a key intermediate in the development of pharmaceuticals and bioactive compounds, contributing to the creation of new materials with potential medicinal applications.
Used in the Development of New Materials:
The presence of the chloro and methyl groups in 5-CHLORO-7-METHYL-6-AZAINDOLE's structure imparts specific properties and reactivity, making it useful for the development of new materials with potential applications in various industries.
Used in Chemical Processes:
5-CHLORO-7-METHYL-6-AZAINDOLE serves as a valuable intermediate in chemical processes, enabling the synthesis of diverse chemical compounds with potential industrial and medicinal applications.

InChI:InChI=1S/C8H7ClN2/c1-5-8-6(2-3-10-8)4-7(9)11-5/h2-4,10H,1H3

Upstream product

• 22280-60-0 6-chloro-4-methyl-3-nitropyridine 
• 1826-67-1 vinyl magnesium bromide 

Relevant articles and documents

THERAPEUTIC COMPOUNDS AND USES THEREOF

The present invention relates to compounds of formula (I) and formula (II): and to salts thereof, wherein R1-R4 of formula (I) and R5-R6 of formula (II) have any of the values defined herein, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) of formula (II), or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders.

Phenylaminopropanol derivatives and methods of their use

The present invention is directed to phenylaminopropanol derivatives of formulae I, II, and III: [image] or a pharmaceutically acceptable salt thereof, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromyalgia syndrome, nervous system disorders, and combinations thereof, particularly those conditions selected from the group consisting of major depressive disorder, vasomotor symptoms, stress and urge urinary incontinence, fibromyalgia, pain, diabetic neuropathy, schizophrenia, and combinations thereof.